Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

C4 Therapeutics, Inc. Director's Dealing 2020

Oct 7, 2020

33861_dirs_2020-10-06_c54d58d3-156c-4557-81dd-4549c94e816e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: C4 Therapeutics, Inc. (CCCC)
CIK: 0001662579
Period of Report: 2020-10-06

Reporting Person: Anderson Kenneth Carl (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-06 Common Stock C 18040 Acquired 80376 Direct
2020-10-06 Common Stock C 18040 Acquired 45038 Indirect
2020-10-06 Common Stock C 41244 Acquired 63543 Indirect
2020-10-06 Common Stock C 41244 Acquired 63543 Indirect
2020-10-06 Common Stock C 16939 Acquired 16939 Indirect
2020-10-06 Common Stock C 16939 Acquired 16939 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-10-06 Series A Preferred Stock $ C 152160 Disposed Common Stock (18040) Direct
2020-10-06 Series A Preferred Stock $ C 152160 Disposed Common Stock (18040) Indirect
2020-10-06 Series A Preferred Stock $ C 347840 Disposed Common Stock (41244) Indirect
2020-10-06 Series A Preferred Stock $ C 347840 Disposed Common Stock (41244) Indirect
2020-10-06 Series B Preferred Stock $ C 142857 Disposed Common Stock (16939) Indirect
2020-10-06 Series B Preferred Stock $ C 142857 Disposed Common Stock (16939) Indirect

Footnotes

F1: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.

F2: Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F3: Shares held the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F4: Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F5: Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.